Premarin combined with Vagifem

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 2/1/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 7/5/2000 59 Female 2/28/2006 Consumer United States
Primary
Secondary
Vertigo Hospitalization 4/10/2001 65 Female 152 lb 2/28/2006 Physician United States
Primary
Concomitant
Hypertension Hospitalization 10/10/2003 55 Female 168 lb 3/16/2006 Lawyer United States
Primary
Concomitant
Transient Ischaemic Attack Hospitalization 10/1/2003 55 Female 168 lb 3/24/2006 Physician United States
Primary
Concomitant
Vomiting Other Serious 7/9/2002 77 Female 130 lb 4/21/2006 United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 4/21/2006 Physician United States
Primary
Secondary
Concomitant
Vertigo Hospitalization 4/10/2001 65 Female 152 lb 5/15/2006 Physician United States
Primary
Concomitant
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 6/1/2006 Physician United States
Primary
Secondary
Concomitant
Burning Sensation 4/3/2006 62 Female 110 lb 6/30/2006 Consumer United States
Primary
Concomitant
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 52 Female 8/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Recurrent Other Serious 12/1/1999 52 Female 8/14/2006 United States
Primary
Secondary
Myocardial Infarction Other Serious 1/1/1999 Female 200 lb 11/29/2006 United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 1/1/1999 Female 200 lb 12/11/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2004 Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Muscle Atrophy Other Serious Female 7/10/2007 Pharmacist Canada
Primary
Concomitant
Endometrial Cancer Death 5/1/2002 7/31/2007 Lawyer United States
Primary
Concomitant
Syncope Vasovagal Life Threatening 8/4/2007 70 Female 159 lb 8/16/2007 Other Health Professional United States
Primary
Concomitant
Muscle Atrophy Other Serious 8/15/2006 Female 140 lb 8/23/2007 Pharmacist Canada
Primary
Concomitant
Muscle Atrophy Other Serious 8/15/2006 Female 140 lb 8/28/2007 Pharmacist Canada
Primary
Concomitant
Breast Cancer Recurrent Other Serious 5/27/2004 Female 3/3/2008 Consumer United States
Primary
Secondary
Weight Decreased Other Serious 1/1/1997 51 Female 123 lb 5/25/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 12/1/1999 52 Female 4/14/2008 Consumer United States
Primary
Secondary
Breast Cancer Recurrent Other Serious 5/27/2004 Female 5/9/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 12/1/1999 Female 5/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 5/22/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/13/1999 Female 195 lb 6/13/2008 Consumer United States
Primary
Secondary
Weight Increased Other Serious 5/1/2008 Female 121 lb 7/7/2008 Other Health Professional United States
Primary
Concomitant
Wheezing 6/17/2008 73 Female 8/5/2008 Consumer United States
Primary
Concomitant
Wheezing 6/17/2008 73 Female 8/26/2008 Consumer United States
Primary
Concomitant
Metastases To Bone Other Serious 12/16/2004 Female 167 lb 9/3/2008 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/16/2001 Female 177 lb 9/5/2008 Consumer United States
Primary
Secondary
Metastases To Bone Other Serious 12/16/2004 Female 167 lb 10/3/2008 Lawyer United States
Primary
Secondary
Weight Increased Other Serious 5/1/2008 Female 121 lb 10/31/2008 Other Health Professional United States
Primary
Concomitant
Breast Cancer Other Serious 3/12/1995 49 Female 200 lb 10/9/2008 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 52 Female 11/11/2008 Lawyer United States
Primary
Secondary
Breast Cancer Stage Ii Hospitalization 11/23/2004 Female 138 lb 11/11/2008 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/1/2004 52 Female 11/13/2008 Lawyer United States
Primary
Secondary
Swelling Disability 4/27/2008 Female 120 lb 11/14/2008 Pharmacist United States
Primary
Concomitant
Breast Cancer Metastatic Other Serious 12/1/1999 Female 11/24/2008 Consumer United States
Primary
Secondary
Lung Cancer Metastatic Other Serious Female 108 lb 12/8/2008 Other Health Professional United States
Primary
Concomitant
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/13/2003 54 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/23/2004 54 Female 12/19/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/20/2004 Female 126 lb 2/12/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/20/2004 Female 126 lb 2/20/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer In Situ Other Serious 7/10/2000 Female 3/30/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/15/2002 Female 139 lb 5/6/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/21/2004 Female 121 lb 5/11/2009 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 1/1/2004 Female 5/18/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1999 Female 5/20/2009 Lawyer United States
Primary
Secondary
Vulvovaginal Mycotic Infection Other Serious 12/1/2008 63 Female 7/20/2009 Consumer United States
Primary
Secondary
Concomitant
Vulvovaginal Mycotic Infection Other Serious 12/1/2008 63 Female 7/23/2009 Consumer United States
Primary
Secondary
Concomitant
Vulvovaginal Mycotic Infection Other Serious 12/1/2008 63 Female 8/21/2009 Consumer United States
Primary
Secondary
Concomitant
Vulvovaginal Mycotic Infection Other Serious 12/1/2008 63 Female 207 lb 9/1/2009 Consumer United States
Primary
Secondary
Concomitant
Tension Hospitalization 4/1/2009 67 Female 11/30/2009 Physician United States
Primary
Secondary
Concomitant
Death Death Female 12/11/2009 Consumer United States
Primary
Secondary
Uterine Prolapse Other Serious 3/15/2002 Female 154 lb 1/28/2010 Lawyer United States
Primary
Secondary
Concomitant
Pain In Extremity Other Serious 4/1/2009 67 Female 121 lb 2/3/2010 Physician United States
Primary
Secondary
Concomitant
Vitamin D Decreased Hospitalization 1/1/2008 Female 2/8/2010 Consumer United States
Primary
Secondary
Concomitant
Vomiting Hospitalization 9/1/2007 73 Female 129 lb 3/10/2010 Lawyer United States
Primary
Concomitant
Breast Cancer Female Other Serious 11/23/2004 54 Female 130 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 11/23/2004 54 Female 130 lb 6/23/2010 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/13/1999 52 Female 194 lb 4/5/2010 United States
Primary
Secondary
Concomitant
Wheezing 1/1/2009 65 Female 141 lb 7/27/2010 Other Health Professional United States
Primary
Concomitant
Myalgia Other Serious 8/4/2010 55 Female 8/5/2010 Pharmacist United States
Primary
Concomitant
Pain In Extremity Other Serious 4/1/2009 67 Female 121 lb 8/11/2010 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious Female 8/19/2010 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2001 51 Female 8/23/2010 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 5/1/2002 53 Female 8/26/2010 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 4/22/2008 55 Female 9/8/2010 Lawyer United States
Primary
Secondary
Drug Ineffective 1/1/2009 62 Female 135 lb 9/9/2010 Consumer United States
Primary
Concomitant
Breast Cancer Other Serious 3/15/2002 55 Female 9/17/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 4/23/2003 52 Female 9/17/2010 Consumer United States
Primary
Secondary
Deep Vein Thrombosis Other Serious 9/10/2003 51 Female 9/17/2010 Lawyer United States
Primary
Secondary
Product Quality Issue 5/15/2009 64 Female 9/23/2010 Pharmacist United States
Primary
Concomitant
Breast Cancer Other Serious 10/12/2007 64 Female 10/27/2010 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/22/2007 60 Female 10/27/2010 Consumer United States
Primary
Secondary

Drug Data